Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), a new unit that aims to build relationships with academics and entrepreneurs developing disruptive ideas to improve patients' lives.

Japan-based drugs company Takeda Pharmaceuticals could launch its early-stage development initiative as early as next month after a shake-up of its corporate venturing unit. Juan Harrison has moved from Takeda Ventures (TVI) to head up New Frontier Science (NFS), a new unit that aims to build relationships with academics and entrepreneurs developing disruptive ideas to…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.